This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

SOLVD - treatment arm

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This multicentre, randomised, double-blind, placebo-controlled trial enrolled 2569 patients with reduced left ventricular function (ejection fraction <35%) and symptomatic heart failure.

The addition of enalapril to the conventional heart failure therapy was found to significantly:

  • reduce mortality by 16%
  • reduce hospitalisation for heart failure by 26%


  • SOLVD Investigators. (1991). N Engl J Med. 325, 293-302.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page